Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden

Inflammatory Bowel Diseases

Volumn 17, Issue 3, 2011, Pages 816-822

  Shu, Xiaochen ^a   Ji, Jianguang ^a   Sundquist, Jan ^b   Sundquist, Kristina ^c   Hemminki, Kari ^d  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cancer survival; colorectal cancer; hazard ratios; inflammatory bowel disease; mortality

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CANCER; ENTERITIS; FEMALE; GENDER; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYELOMA; NERVE TUMOR; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE CANCER; RECTUM CANCER; RESPIRATORY TRACT CANCER; SMALL INTESTINE CANCER; STOMACH CANCER; SWEDEN; THYROID CANCER;

ADULT; AGED; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL RATE; SWEDEN;

EID: 79951605275     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21380     Document Type: Article

References (26)

1. MacDonald TT, Monteleone G,. Overview of role of the immune system in the pathogenesis of inflammatory bowel disease. Adv Exp Med Biol. 2006; 579: 98-107.
2. Hutfless SM, Weng X, Liu L, et al. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology. 2007; 133: 1779-1786. (Pubitemid 350180814)
3. Baumgart DC, Carding SR,. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369: 1627-1640. (Pubitemid 46722636)
4. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991; 100: 350-358.
5. Lapidus A, Bernell O, Hellers G, et al. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut. 1997; 41: 480-486. (Pubitemid 27448779)
6. Hemminki K, Li X, Sundquist J, et al. Cancer risks in Crohn disease patients. Ann Oncol. 2009; 20: 574-580.
7. Hemminki K, Li X, Sundquist J, et al. Cancer risks in ulcerative colitis patients. Int J Cancer. 2008; 123: 1417-1421.
8. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001; 91: 854-862. (Pubitemid 32173312)
9. Mellemkjaer L, Olsen JH, Frisch M, et al. Cancer in patients with ulcerative colitis. Int J Cancer. 1995; 60: 330-333.
10. Brackmann S, Aamodt G, Andersen SN, et al. Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer. Inflamm Bowel Dis. 2010; 16: 474-481.
11. Lutgens MW, Oldenburg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009; 101: 1671-1675.
12. Larsen M, Mose H, Gislum M, et al. Survival after colorectal cancer in patients with Crohn's disease: a nationwide population-based Danish follow-up study. Am J Gastroenterol. 2007; 102: 163-167. (Pubitemid 46072057)
13. Epidemiology Cf,. Cancer Incidence in Sweden 2005. Stockholm, Sweden: The National Board of Health and Welfare 2007.
14. Ji J, Forsti A, Sundquist J, et al. Survival in ovarian cancer patients by histology and family history. Acta Oncol. 2008; 47: 1133-1139.
15. Hemminki K, Ji J, Forsti A, et al. Survival in breast cancer is familial. Breast Cancer Res Treat. 2008; 110: 177-182. (Pubitemid 351793857)
16. Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005; 54: 617-622. (Pubitemid 40559243)
17. Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006; 101: 1283-1287. (Pubitemid 43829994)
18. Delaunoit T, Limburg PJ, Goldberg RM, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006; 4: 335-342. (Pubitemid 43343890)
19. Jess T, Loftus EV Jr, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut. 2006; 55: 1248-1254. (Pubitemid 44277354)
20. Choi PM, Nugent FW, Schoetz DJ Jr, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993; 105: 418-424. (Pubitemid 23213526)
21. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998; 42: 711-714. (Pubitemid 28261062)
22. de Visser KE, Eichten A, Coussens LM,. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006; 6: 24-37. (Pubitemid 43053650)
23. Rosenberg SA,. Progress in human tumour immunology and immunotherapy. Nature. 2001; 411: 380-384. (Pubitemid 32467048)
24. Wellmann A, Fogt F, Hollerbach S, et al. Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease. J Cancer Res Clin Oncol. 2010; 136: 795-802.
25. Roifman I, Sun YC, Fedwick JP, et al. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009; 7: 175-182.
26. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology. 1992; 103: 954-960.